We are live on
!
Find out more
FPB
First PREMIER Bank Portfolio holdings
AUM
$619M
1-Year Est. Return
20.21%
This Fund
S&P 500
This Quarter
Est. Return
-1.95%
1 Year Est. Return
+20.21%
3 Year Est. Return
+54.38%
5 Year Est. Return
+59.67%
10 Year Est. Return
+189.02%
AUM
$379M
AUM Growth
-$6.88M
(-1.8%)
Cap. Flow
+$2.71M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
34.84%
Holding
391
New
30
Increased
88
Reduced
52
Closed
25
Top Buys
| 1 |
Invesco S&P 500 Downside Hedged ETF
PHDG
|
+$2.09M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$1.69M |
| 3 |
Vanguard Value ETF
VTV
|
+$802K |
| 4 |
Vanguard Small-Cap ETF
VB
|
+$612K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$475K |
Top Sells
| 1 |
SAB Biotherapeutics
SABS
|
+$6.5M |
| 2 |
Vanguard Total Bond Market
BND
|
+$746K |
| 3 |
GE Aerospace
GE
|
+$467K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$337K |
| 5 |
iShares Gold Trust
IAU
|
+$316K |
Sector Composition
| 1 | Utilities | 10.96% |
| 2 | Technology | 9.31% |
| 3 | Financials | 7.26% |
| 4 | Healthcare | 7.25% |
| 5 | Industrials | 6.52% |
Similar funds
RIS
AMG
KGAMU
KFAS
BWP
MC
ACP
RC
First PREMIER Bank's Q1 2022 Portfolio in Review
As of Q1 2022, First PREMIER Bank held 391 positions worth $379M, down 1.8% from $386M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
First PREMIER Bank's Q1 2022 filing shows 30 new, 88 increased, 52 reduced and 25 closed positions. Its largest new stake was Thermo Fisher Scientific: 800 shares worth $473K. The largest sale was SAB Biotherapeutics, an estimated $6.5M.
By sector, the portfolio is most concentrated in Utilities at 11% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
- First PREMIER Bank's largest Q1 2022 buy was Thermo Fisher Scientific: 800 shares worth $473K.
- First PREMIER Bank added most to Invesco S&P 500 Downside Hedged ETF in Q1 2022, an estimated $2.09M increase.
- First PREMIER Bank's biggest Q1 2022 reduction was Vanguard Total Bond Market, cutting an estimated $746K.
- First PREMIER Bank fully exited SAB Biotherapeutics in Q1 2022, selling an estimated $6.5M.
- First PREMIER Bank's ten largest holdings make up 35% of its $379M portfolio in Q1 2022.
- First PREMIER Bank opened 30 new positions and closed 25 in Q1 2022.
- First PREMIER Bank's portfolio value fell 1.8% quarter-over-quarter to $379M.
Based on First PREMIER Bank's 13F filing for Q1 2022, filed 25 Apr 2022.